Novartis Sandoz unit may be a tough pill for buyers to swallow: Bloomberg Ruchika Sharma4 Feb 2022 3:06 PM ISTNew Delhi: Novartis AG expects revenue at its generic-drugs unit to continue declining in the U.S. throughout this year, highlighting some of the...
Novartis pushes forward with Covid drug after positive trial: Bloomberg Ruchika Sharma12 Jan 2022 2:11 PM ISTNovartis's medicine is given via an intravenous infusion, making a doctor's visit necessary.
Novartis gets CDSCO panel nod to study Alpelisib for early (prophylactic) and sustained improvement of hyperglycemia Medical Dialogues Team9 Jan 2022 8:45 PM ISTNew Delhi: Pharmaceutical major Novartis has got a conditional nod from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Novartis gets CDSCO panel nod to study Ligelizumab in treatment of chronic inducible urticaria Medical Dialogues Team7 Jan 2022 2:21 PM ISTNew Delhi: Pharma major Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Novartis wins appeal over MS drug Gilenya patent: Bloomberg Medical Dialogues Bureau5 Jan 2022 10:00 AM ISTThe issue on appeal was whether the patent clearly explained the dosage regimen for fingolimod, the active ingredient in Gilenya, without the need for...
Novartis Cosentyx gets USFDA approval Ruchika Sharma26 Dec 2021 9:45 AM ISTBasel: Novartis has announced the US Food and Drug Administration (USFDA) has approved Cosentyx (secukinumab) for the treatment of active...
Ligelizumab fails to show superiority to omalizumab in chronic spontaneous urticaria: Clinical trials Hina Zahid25 Dec 2021 9:00 AM ISTLigelizumab, an investigational treatment for chronic spontaneous urticaria (CSU), failed to show superiority to omalizumab in two identical phase 3...
Delhi HC restrains Natco from infringing Novartis API containing Eltrombopag Olamine Medical Dialogues Team22 Dec 2021 6:26 PM ISTNew Delhi: In a major relief to Novartis, the Delhi High Court has restrained Natco Pharma from using, manufacturing , importing, selling, offering...
Working on pan-coronavirus oral treatment: Novartis CEO Ruchika Sharma7 Dec 2021 2:46 PM ISTNew Delhi: Novartis hopes to still play a role in the development of COVID-19 treatments with research ongoing for a pill that could work broadly...
Pfizer vaccine executive Phil Dormitzer to join GSK as Global Head of Vaccines RnD Ruchika Sharma1 Dec 2021 12:00 PM ISTUnited Kingdom: Drug maker, GSK, has recently announced that Phil Dormitzer M.D., Ph.D., will join the company as Global Head of Vaccines R&D on 3...
Health Bulletin 26/November/2021 Roshni Dhar26 Nov 2021 5:42 PM ISTHere are Top Health stories of the dayHospitals Demand Revision of CGHS rates, Minister promises early actionDoctors and Hospitals working under...
Health Bulletin 25/November/2021 Roshni Dhar25 Nov 2021 6:15 PM ISTHere are Top Health stories of the dayDoctors Shortage In Govt Run Hospitals: Delhi High Court Issues Notice On Plea For Filling Vacancies as soon as...
